Medication
Cetirizine
DIN 02515695 · Sanis Health Inc
What it is
- Active ingredients
- Cetirizine Hydrochloride — 20 mg
- Form and route
- Tablet · Oral
- Schedule
- PRESCRIPTION
- Authorised since
- 2021-11-30
Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.
Products with the same active ingredient
- Reactine 20 MG Tablet
- PMS-Cetirizine
- Mar-Cetirizine
- Pro-Cetirizine
- Apo-Cetirizine
- Jamp-Cetirizine
- Nat-Cetirizine
- Bio-Cetirizine
- M-Cetirizine
- Teva-Cetirizine
- Nra-Cetirizine Tablets
- Cetirizine
Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.
Watch this medication
Ontario Drug Benefit coverage
As of 31 July 2026Off-formulary interchangeable Part III-B
Ontario has designated this product interchangeable with a brand product, but it is not an ODB benefit — Part III-B, Off-Formulary Interchangeable. Ontario does not pay for it under the benefit list.
Source: Ontario Ministry of Health — ODB Formulary. Data current as of 2026-07-28. Ontario only. Formulary edition 4342, effective 31 July 2026.
Products Ontario considers interchangeable
As of 31 July 2026Ontario groups these products together at 20mg Tab and will substitute one for another at a pharmacy counter in Ontario.
- Apo-Cetirizine 02453363Apotex Inc
- Cetirizine 02534126Sivem Pharmaceuticals ULC
- Jamp-Cetirizine 02466171Jamp Pharma Corporation
- M-Cetirizine 02512025Mantra Pharma Inc
- Mar-Cetirizine 02427141Marcan Pharmaceuticals Inc
- Nat-Cetirizine 02496488Natco Pharma (Canada) Inc
- Nra-Cetirizine Tablets 02530236Nora Pharma Inc
- PMS-Cetirizine 02315963Pharmascience Inc
- Reactine 20 MG Tablet 01900978Kenvue Canada Inc.
- Teva-Cetirizine 02528681Teva Canada Limited
Ontario lists 3 further products in this group that are not currently marketed in Canada. They are not shown.
This is Ontario’s designation, under the Ontario Drug Benefit program, and it applies in Ontario. It is a different statement from the same-active-ingredient list above, which is Health Canada’s grouping and carries no substitution meaning at all. No other province’s rules are shown on this page, and a designation here is not a recommendation to switch — that is a conversation with a pharmacist or prescriber.
Source: Ontario Ministry of Health — ODB Formulary. Data current as of 2026-07-28. Ontario only. Formulary edition 4342, effective 31 July 2026.
How it is classified
- Anatomical main group
- Respiratory system
- ATC code
- R06AE07
The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of R06AE07, see the WHO ATC/DDD Index.
Recalls and safety alerts
As of 12 August 2026Possible matches
These notices name a product name that more than one company sells. They may or may not concern this manufacturer’s product — Health Canada’s data does not say. They are not recalls of this product.
Cetirizine 20 mg tablet: Out of Specification (Impurities)
Possible match. This notice names “CETIRIZINE”, and 2 authorised products from 2 companies are sold under that name. The notice does not say which of them is affected.
This list may be incomplete. Health Canada’s recalls data carries no DIN, so notices are matched on wording alone. Search Health Canada recalls for Cetirizine → How RxMonitor matches recalls, and how often it fails
Source: Health Canada — Recalls and Safety Alerts. Data current as of 2026-08-12. Matched on product name, not on DIN — the feed carries none.